13F HOLDINGS REPORT
Artal Group S.A.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001053906-25-000002
Total Value
$1.17B
Positions
2
Other Managers
5
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 9,507,990 | $1.07B | 91.41% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $100.8M | 8.59% |